The UBE2B (Ubiquitin-Conjugating Enzyme E2 B) gene encodes a member of the ubiquitin-conjugating enzyme family that plays essential roles in protein ubiquitination, DNA repair, synaptic function, and neuronal development. Formerly known as HR6B (Rad6 homolog B), UBE2B works in conjunction with the E3 ubiquitin ligase RAD18 to catalyze the monoubiquitination of histone H2A and other substrates. The gene is located on chromosome 5q31.1 and is highly expressed in the brain, where it performs critical functions in synaptic plasticity, learning and memory, and proteostasis.
| Property | Value |
|---|---|
| Gene Symbol | UBE2B |
| Full Name | Ubiquitin-Conjugating Enzyme E2 B |
| Synonyms | HR6B, RAD6B, E2-17kDa |
| Chromosomal Location | 5q31.1 |
| NCBI Gene ID | 7332 |
| **UniProt ID | P63146 |
| Protein Length | 152 amino acids |
| Molecular Weight | ~17 kDa |
The UBE2B gene spans approximately 6 kb on chromosome 5q31.1 and consists of 4 exons. The gene encodes a 152-amino acid protein that is highly conserved across eukaryotes. UBE2B shares significant homology with its yeast homologs RAD6 and UBC2, reflecting conserved functions in DNA repair and other cellular processes.
UBE2B contains the characteristic ubiquitin-conjugating enzyme (E2) domain:
N-terminal domain: Contains the catalytic cysteine residue that forms a thioester bond with ubiquitin. This region is essential for enzymatic activity.
Core domain: The conserved UBCc (Ubiquitin-Conjugating Enzyme C-terminus) domain that adopts a fold unique to E2 enzymes.
C-terminal region: Contains additional regulatory elements that influence enzyme specificity and interactions.
The protein localizes primarily to the nucleus, where it participates in chromatin-related functions, and to the cytoplasm, where it contributes to synaptic protein regulation.
UBE2B functions as a key E2 enzyme in the ubiquitin-proteasome system:
Catalytic activity:
Substrate specificity:
UBE2B has relatively broad substrate specificity, working with multiple E3 ligases:
A major function of UBE2B is in DNA repair pathways:
Translesion DNA synthesis:
Histone H2A ubiquitination:
UBE2B plays crucial roles in neuronal synapses:
AMPA receptor trafficking:
Research by Yang et al. (2020) demonstrated that UBE2B regulates AMPA receptor trafficking, a critical process for synaptic plasticity. The enzyme modifies proteins involved in receptor endocytosis and recycling.
Synaptic protein turnover:
UBE2B contributes to the regulated turnover of synaptic proteins, enabling dynamic remodeling of synaptic structure and function during learning and memory formation.
UBE2B is essential for proper brain development:
Neuronal differentiation:
Studies by Davis et al. (2019) showed that UBE2B affects neurogenesis and neuronal differentiation during brain development.
Brain wiring:
Proper UBE2B function contributes to the formation of neural circuits through effects on protein turnover and synaptic assembly.
UBE2B may contribute to Alzheimer's disease pathogenesis:
Protein homeostasis:
Wang et al. (2021) demonstrated UBE2B involvement in proteostasis, which is disrupted in AD. Dysregulation could contribute to protein aggregation.
Amyloid metabolism:
UBE2B may affect amyloid precursor protein (APP) processing through ubiquitin-mediated pathways.
Tau pathology:
UBE2B-mediated ubiquitination could influence tau turnover and aggregation.
UBE2B connections to Parkinson's disease include:
Alpha-synuclein turnover:
Miller et al. (2020) showed UBE2B involvement in protein aggregation in neurodegenerative diseases, potentially affecting alpha-synuclein clearance.
Mitochondrial quality control:
Johnson et al. (2019) demonstrated UBE2B functions in mitochondrial quality control, relevant to PD pathogenesis where mitochondrial dysfunction is central.
LRRK2 regulation:
UBE2B may interact with LRRK2 signaling pathways, though direct evidence is limited.
UBE2B mutations are associated with neurodevelopmental disorders:
Cognitive impairment:
Smith et al. (2019) identified UBE2B mutations in patients with intellectual disability and autism, highlighting the importance of this gene for cognitive function.
Mouse model studies:
Kim et al. (2019) showed that UBE2B-deficient mice exhibit learning and memory deficits, providing mechanistic insights.
UBE2B dysfunction may contribute to psychiatric conditions:
UBE2B catalyzes ubiquitin transfer through a well-characterized mechanism:
Thioester formation: UBE2B forms a high-energy thioester intermediate with ubiquitin, activated by the E1 enzyme.
Substrate attack: The catalytic cysteine attacks the target protein's amino group, forming an isopeptide bond.
Product release: The ubiquitinated product is released, completing the reaction.
For polyubiquitin chain formation, UBE2B can add additional ubiquitin molecules to the initial monoubiquitin.
UBE2B interacts with multiple proteins:
E3 ligases:
Substrates:
Other partners:
UBE2B activity is regulated through multiple mechanisms:
Transcriptional control:
Post-translational modifications:
Cellular localization:
Modulating UBE2B activity has therapeutic potential:
Enhancement strategies:
Inhibition approaches:
Brain delivery:
Targeting brain UBE2B requires overcoming the blood-brain barrier.
Specificity:
UBE2B has overlapping functions with UBE2A, complicating specific targeting.
Therapeutic window:
Balancing enhancement versus inhibition requires careful dosing and timing considerations.
Key methods for studying UBE2B include: